Nature Reviews Clinical Oncology

Vol. 22, Issue 10 Issue 10 2025
8
Articles

Articles in this Issue

ASTER 70 suggests no clinical benefit from adjuvant chemotherapy in older patients with ER+HER2– breast cancer

David Killock Oct 01, 2025 pp. 707-707 10.1038/s41571-025-01070-6

Cured but breathless: the growing burden of DIILD in cancer survivors

Jing-Xing Li, Wen-Chien Cheng Oct 01, 2025 pp. 703-705 10.1038/s41571-025-01064-4

Rethinking cancer of unknown primary: from diagnostic challenge to targeted treatment

Maria Pouyiourou, Tilmann Bochtler, Chantal Pauli et al. Oct 01, 2025 pp. 781-799 10.1038/s41571-025-01060-8

Understanding and overcoming multidrug resistance in cancer

Minghua Ge, Xuan-Yu Chen, Ping Huang et al. Oct 01, 2025 pp. 760-780 10.1038/s41571-025-01059-1

PROTAC SERD vepdegestrant outperforms fulvestrant for advanced-stage ER+HER2− breast cancer harbouring acquired ESR1 mutations

Patrick Neven, Sileny N. Han Oct 01, 2025 pp. 709-710 10.1038/s41571-025-01062-6

EMT and cancer: what clinicians should know

Erik W. Thompson, Andrew D. Redfern, Simone Brabletz et al. Oct 01, 2025 pp. 711-733 10.1038/s41571-025-01058-2

Therapeutic targeting of mismatch repair-deficient cancers

Paul Johannet, Benoit Rousseau, Carol Aghajanian et al. Oct 01, 2025 pp. 734-759 10.1038/s41571-025-01054-6

Perioperative pembrolizumab demonstrates clinical benefit in locally advanced HNSCC

David Killock Oct 01, 2025 pp. 707-707 10.1038/s41571-025-01057-3

All Issues

Issue 7 - Issue 7 11 Issue 6 - Issue 6 10 Issue 5 - Issue 5 10 Issue 4 - Issue 4 10 Issue 3 - Issue 3 10 Issue 2 - Issue 2 9 Issue 1 - Issue 1 12
Issue 9 - Issue 9 11 Issue 8 - Issue 8 14 Issue 7 - Issue 7 10 Issue 6 - Issue 6 9 Issue 5 - Issue 5 11 Issue 4 - Issue 4 10 Issue 3 - Issue 3 12 Issue 2 - Issue 2 8 Issue 12 - Issue 12 13 Issue 11 - Issue 11 9 Issue 10 - Issue 10 8 Issue 1 - Issue 1 12

Journal Info

Publisher Springer Science and Business Media LLC
ISSN 1759-4774
E-ISSN 1759-4782
Subject Medicine
Language English
View Full Journal Page